True regenerative cartilage product.

Program ST04

 

  • Single treatment cycle of intra-articular application leads to long-term benefits

  • True regenerative cartilage product

  • Pain reduction

  • Superior product candidate due to unique mode of action

  • Pre-clinical development of ST04 is nearly completed

    • Seven pharmacodynamics studies in small and large animals

    • Long term observation in large animals

    • GLP tox studies

  • Sound prove of concept data (POC) from comprehensive data set from state of the art relevant animal models; strong in vivo data package

  • Translatable biomarker for clinical trials: reduced clinical development effort; cost efficient route to clinical prove of concept